Evaluating the efficacy of different doses of tocilizumab in treating critically ill COVID–19 patients: a single–center retrospective cohort study
ObjectivesTo evaluate the therapeutic efficacy of different doses of tocilizumab (TCZ) in patients with severe or critical COVID–19.MethodsIn this single–center retrospective cohort study conducted from January 2023 to January 2024, 56 hospitalized patients with severe or critical COVID–19 who recei...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1571372/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|